Home Cart Sign in  
Chemical Structure| 1105698-15-4 Chemical Structure| 1105698-15-4

Structure of Salermide
CAS No.: 1105698-15-4

Chemical Structure| 1105698-15-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Salermide, a reverse amide, can act as an inhibitor of sirt, especially of sirt2, with the property of inducing apoptosis of tumor cells.

Synonyms: Salermide

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Salermide

CAS No. :1105698-15-4
Formula : C26H22N2O2
M.W : 394.47
SMILES Code : CC(C1=CC=CC=C1)C(NC2=CC=CC(/N=C/C3=C4C=CC=CC4=CC=C3O)=C2)=O
Synonyms :
Salermide
InChI Key :HQSSEGBEYORUBY-UHFFFAOYSA-N
Pubchem ID :135659046

Safety of Salermide

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H317-H412
Precautionary Statements:P273-P280

Related Pathways of Salermide

epigenetics

Isoform Comparison

Biological Activity

Target
  • SIRT1

In Vitro:

Cell Line
Concentration Treated Time Description References
Acanthamoeba castellanii trophozoites 100 μM 24 and 48 hours Inhibited the proliferation of Acanthamoeba castellanii trophozoites PMC7376869
H1650 20 μM 24 hours To evaluate the apoptosis effect of Salermide on H1650 cells, results showed H1650 cells were particularly sensitive to Salermide. PMC3823229
HCT116 Oxa-R cells 20 μM 24 hours To evaluate the effect of CAY10602 on oxaliplatin resistance, results showed that CAY10602 enhancement of SIRT1 expression decreased the resistance of HCT116 Oxa-R cells to oxaliplatin. PMC11924001
HCT116 Oxa-R cells 10 μM 24 hours To evaluate the effect of Salermide on oxaliplatin resistance, results showed that Salermide inhibition of SIRT1 expression increased the resistance of HCT116 Oxa-R cells to oxaliplatin. PMC11924001
BxPC-3 cells 5-100 µM 24 hours To evaluate the effect of Salermide alone or in combination with EF24 on the viability of BxPC-3 cells. Results showed that Salermide alone significantly reduced the viability of BxPC-3 cells with an IC50 value of approximately 40 µM. PMC4908665
H157 50 μM 24, 48 hours To evaluate the time-dependent apoptosis induced by Salermide, results showed apoptosis started at 24 hrs and peaked at 48 hrs. PMC3823229
Acanthamoeba castellanii trophozoites 100 μM 24, 48, 72 hours Inhibited the proliferation of Acanthamoeba castellanii trophozoites PMC7376869
Human brain microvascular endothelial cells and astrocytes co-culture model 50 μM 30 min pretreatment Sirt1 inhibition significantly reduced BBB permeability (increased TEER) and attenuated OGD-induced apoptosis and mitochondrial ROS generation PMC5633840
SKOV-3 cells 50 μM 48 hours Comparison of anticancer effects between MHY2256 and salermide in SKOV-3 cells, showing IC50 values of salermide as 36.5-50.9 μM PMC5166496
MCF-7 cells 50 μM 48 hours Comparison of anticancer effects between MHY2256 and salermide in MCF-7 cells, showing IC50 values of salermide as 36.5-50.9 μM PMC5166496
H1792 12.5, 25, 50 μM 48 hours To evaluate the effect of Salermide on cell growth, results showed Salermide induced growth inhibition in a concentration-dependent manner. PMC3823229
Ishikawa endometrial cancer cells 0.1–50 μM 48 hours To compare the cytotoxicity of MHY2256 and Salermide on Ishikawa cells. Results showed that the IC50 value of MHY2256 was approximately 10-fold lower than that of salermide. PMC6164480
LLCMK2 cells 2 μM 48 hours Salermide reduced the number of intracellular parasites in vitro infection assays with minimal effects on host cell viability. PMC4505258
MiaPaca-2 pancreatic cancer cells 25–50 μM 72 hours Inhibited SIRT2 activity, reduced c-Myc protein expression, and suppressed cell proliferation PMC3569991
BE(2)-C neuroblastoma cells 25–50 μM 72 hours Inhibited SIRT2 activity, reduced N-Myc protein expression, and suppressed cell proliferation PMC3569991
Trypanosoma cruzi epimastigotes 5 μM 72 hours Salermide significantly inhibited parasite growth and differentiation, with an EC50 of 10.6 μM. PMC4505258
Acanthamoeba castellanii encysting cells 100 μM 72 hours Inhibited the encystation of Acanthamoeba castellanii PMC7376869

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Zebrafish Dmd mutant zebrafish Embryo bath 1 μM From 1 dpf to 4 dpf, changing the treatment solution daily To evaluate the effect of Salermide in combination with oxamflatin on the skeletal muscle structure of dmd mutant zebrafish. Results showed that the combination significantly ameliorated skeletal muscle degeneration. PMC7559456
BALB/c nude mice Subcutaneous xenograft model of HCT116 Oxa-R cells in nude mice Subcutaneous injection 10 mg/kg Three times a week until tumor volume reached 1500 mm³ To evaluate the effect of CAY10602 on oxaliplatin resistance, results showed that CAY10602 enhanced the growth-inhibitory effect of oxaliplatin on HCT116 Oxa-R cells. PMC11924001
BALB/c mice Chagas disease model Intraperitoneal injection 100 μM Daily for 12 days Salermide partially controlled in vivo infection, reducing parasitemia. PMC4505258
Nude mice MCF-7 xenograft model Intraperitoneal injection 30 mg/kg Once per week for 4 weeks Evaluation of the antitumor effects of salermide in the MCF-7 xenograft model, showing significant inhibition of tumor growth PMC5166496
Nude mice Ishikawa endometrial cancer cell xenograft model Intraperitoneal injection 30 mg/kg Once per week for 30 days To evaluate the antitumor effect of Salermide on Ishikawa cell xenograft model. Results showed that salermide significantly inhibited tumor growth. PMC6164480
Mice Photothrombotic stroke model Intracerebroventricular injection 400 μM Single administration, 1 hour after stroke To study the effect of Salermide on infarction volume and apoptotic index after stroke. Results showed that Salermide did not significantly alter infarction volume or apoptotic index compared to control samples. PMC9092253

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.54mL

0.51mL

0.25mL

12.68mL

2.54mL

1.27mL

25.35mL

5.07mL

2.54mL

References

 

Historical Records

Categories